AB1213-HPR A NATIONAL RHEUMATOID ARTHRITIS REGISTRY SUPPORTED BY A PUBLIC POLICY AS A STRATEGY FOR DISEASE CONTROL AND RISK MANAGEMENT IN COLOMBIA
Background: Rheumatoid arthritis (RA) is a chronic disease that implies high direct and indirect costs for the health system (1,2). According to the needs of the health care system, the clinical interests and the national regulatory framework, it was developed a national registry information of RA patients (3). Objectives: To show how a registry of information that would meet the RA situation was developed and to present the results obtained from the analysis of the Registry on this first year. Methods: A national RA Registry was created after a comprehensive literature review to identify the relevant variables to determine monitoring indicators used by health insurers and health services providers in the attention of patients with RA. Variables were selected and defined by an agreement with clinical experts, thematic and methodological experts and were evaluated by the Ministry of Health in order to review and approve the structure to gather the information. Results: A structure of 89 variables contained was defined. All entities must report annually to the Registry all the patients with a diagnosis of RA, their clinical and demographic characteristics, and the process of care and costs (3). On its first year the Registry provided a baseline of the disease situation of 68.357 patients with RA. Prevalence, incidence, state of disease and drugs including synthetic and biologic DMARDs were analyzed (Table 1) . Most important results were: mean age 57 years; relation women: men 5.2:1; age at onset of disease: 36 years, mean evolution time of disease: 7 years; population with DAS 28 measured 45.6%; mean DAS-28 2.8; percentage of the patient with DMARD therapy 78.9% and bDMARD 16.5%. Conclusions: A national Registry supported by an official policy, with data from the real world provided for healthcare insurers gives an opportunity to obtain a global vision and to identify failures and strengths in the attention process of RA, and to develop indicators to obtain better outcomes. In the future, through continuous efforts towards improving the quality of care provided, these will allow to monitoring and decreasing the burden of RA in the country and may serve as a model to other countries. One hundred and six patients with infectious spondylodicitis hospitalized in the department of rheumatology were analyzed. All patients were thoroughly interrogated subjected to a rigorous clinical examination and a battery of investigations including: complete blood count, urine analysis, blood culture, erythrocyte sedimentation rate, C -reactive protein (CRP) and serology for brucellosis. The imaging of spine ordered including: X-ray, bone scan and magnetic resonance imaging (MRI) with contrast enhancement. Results: Thirty of the 106 patients (28%) proved to have spinal brucellosis. The mean age of these patients was 53 years (range 15-68 years) and female/men ratio at 1.5. The mean delay of diagnosis was 8 months. The following symptoms were observed: fever in 14 patients and back pain in all of patients. Other symptoms were less frequently observed, such as splenomegaly (2 patients), peripheral adenopathy (5 patients) and diarrhea (2 patients). Laboratory exams showed elevated erythrocyte sedimentation rate in 13 patients, high levels of CRP in all patients and leukocytosis in 11 cases. Wright serology was positive in 21 of the patients. Brucella melitensis was isolated in blood cultures in 2 cases. Standard X-rays were performed in all patients. They showed signs of spondylodiscitis in the lumbar spine in 20 cases, cervical in 2 cases and dorsal in 8 cases. Ct-scan and MRI confirms the diagnosis and showed associated epiduritis in 2 cases or abscess in 6 cases. Bone biopsy with histopathological examination was performed in 7 cases. A combination of cycline and rifampicin was given to all patients. The duration of therapy was between 6 and 8 weeks. Conclusions: Brucellosis is present with various clinical signs in endemic areas and may simulate many diseases. The need for prompt diagnosis and treatment of spinal brucellosis is of utmost importance to prevent serious bone destruction and severe neurologic Sequelae. Background: Nitric oxide (NO) is central in the process of vasodilatation (1). Limited bioavailability of NO often associates with endothelial dysfunction, a precursor to atherogenesis (1). Such dysfunction is often observed in patients with chronic conditions such as Rheumatoid Arthritis (RA) (2) and Chronic Obstructive Pulmonary Disease (COPD) (3). Common therapies for this include the administration of nitrate-rich medication. However, in the general population beetroot juice supplementation has been shown to increase NO bioavailability (4). It could therefore have beneficial effects on endothelial function of these patients as well.
